发明名称 |
Use of toll-like receptors and agonist for treating cancer. |
摘要 |
<p>The present invention is directed to methods and agents used for treating cancer or infectious diseases by providing toll-like receptors such as toll-like receptor 5 (TLR-5) in combination with providing a toll-like receptor agonists such as flagellin resulting in a cis and intrans effect that recruits cells involved in both the innate (cis effect) and adaptive (trans effect) immune response to specifically kill cancer cells and cells infected with a pathogen via the NF-&kgr;B apoptosis pathway.</p> |
申请公布号 |
AP201206253(D0) |
申请公布日期 |
2012.06.30 |
申请号 |
AP20120006253 |
申请日期 |
2010.10.06 |
申请人 |
PANACELA LABS INC;ROSWELL PARK CANCER INSTITUTE |
发明人 |
GUDKOV ANDREI |
分类号 |
C12N15/63 |
主分类号 |
C12N15/63 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|